Canada Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 4

2 Introduction 6

• 2.1 What Is This Report About? 6
• 2.2 Diabetes Care Devices Market Segmentation 6
• 2.3 Definitions of Markets Covered in the Report 7

3 Diabetes Care Devices Market, Canada 9

• 3.1 Diabetes Care Devices Market, Canada, Revenue ($m), 2015-2025 9
• 3.2 Diabetes Care Devices Market, Canada, Revenue Mix ($m), 2019 11
• 3.3 Diabetes Care Devices Market, Canada, Category Contribution by Revenue ($m), 2019 12
• 3.4 Diabetes Care Devices Market, Canada, Revenue ($m), 2015-2025 13
• 3.5 Diabetes Care Devices Market, Canada, Volume (Units), 2015-2025 15
• 3.6 Diabetes Care Devices Market, Canada, Volume (Units), 2015-2025 17
• 3.7 Diabetes Care Devices Market, Canada, Company Share by Revenue ($m), 2019 19

4 Glucose Monitoring Market, Canada 21

• 4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2015-2025 21
  • 4.1.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2015-2025 23
• 4.2 Glucose Monitoring Market, Canada, Volume (Units), 2015-2025 25
  • 4.2.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2015-2025 27
• 4.3 Glucose Monitoring Market, Canada, Average Price ($) , 2015-2025 29
• 4.4 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2019 30
• 4.5 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2019 31

5 Insulin Delivery Market, Canada 32

• 5.1 Insulin Delivery Market, Canada, Revenue Mix ($m), 2019 32
• 5.2 Insulin Delivery Market, Canada, Segment Contribution (%), 2019 33
• 5.3 Insulin Delivery Market, Canada, Revenue ($m), 2015-2025 34
  • 5.3.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2015-2025 36
  • 5.3.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2015-2025 38
• 5.4 Insulin Delivery Market, Canada, Volume (Units), 2015-2025 40
  • 5.4.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2015-2025 42
  • 5.4.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2015-2025 44
• 5.5 Insulin Delivery Market, Canada, Average Price ($), 2015-2025 46
• 5.6 Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), 2019 47
• 5.7 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2019 48

6 Overview of Key Companies in Canada, Diabetes Care Devices Market 50

• 6.1 DexCom Inc 50
  • 6.1.1 Company Overview 50
• 6.2 Novo Nordisk AS 50
  • 6.2.1 Company Overview 50
• 6.3 Eli Lilly and Co 50
  • 6.3.1 Company Overview 50
• 6.4 Abbott Laboratories 51
  • 6.4.1 Company Overview 51
• 6.5 Medtronic Plc 51
  • 6.5.1 Company Overview 51
• 6.6 Sanofi 51
  • 6.6.1 Company Overview 51
• 6.7 F. Hoffmann-La Roche Ltd 52
  • 6.7.1 Company Overview 52

7 Diabetes Care Devices Market Pipeline Products 53

8 Financial Deals Landscape 54

• 8.1 Equity Offerings 54
  • 8.1.1 Sernova Raises USD0.1 Million in Private Placement of Units 54
  • 8.1.2 Covalon Technologies Raises USD4.2 Million in Private Placement of Units 55
  • 8.1.3 Sernova Raises USD1.7 Million in Second Tranche of Private Placement of Units 56
  • 8.1.4 Sernova Raises USD1.8 Million in First Tranche of Private Placement of Units 57
  • 8.1.5 Callitas Health Raises USD0.29 Million in Private Placement of Units 58
• 8.2 Partnerships 59
  • 8.2.1 LifeScan Enters into Distribution Agreement with Sanvita Medical 59

9 Recent Developments 60

• 9.1 Corporate Communications 60
  • 9.1.1 Oct 24, 2019: Sernova announces Biotech Veteran as new Chief Financial Officer 60
  • 9.1.2 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 61
  • 9.1.3 Aug 21, 2019: Shield Diagnostics appoints David Esposito to its Board of Directors 61
  • 9.1.4 Jun 07, 2019: Jubilant DraxImage receives CE Mark certificate for its medical device RUBY Rubidium Elution System (RbES) and Proprietary RUBY 62

Consumable Accessories 62

• 9.1.5 May 21, 2019: Sernova names Ms. Deborah Brown to its Board of Directors 63
• 9.1.6 May 09, 2019: Polyphor temporarily halts enrollment in the Phase III studies of murepavadin for the treatment of patients with nosocomial pneumonia 63
• 9.1.7 May 02, 2019: Asuragen announce the launch of AmplideX PCR/CE HTT kit for Huntington’s disease 64

10 Appendix 72

• 10.1 Research Methodology 73
  • 10.1.1 Coverage 73
  • 10.1.2 Secondary Research 73
  • 10.1.3 Primary Research 74
  • 10.1.4 Market Modeling and Forecasting 74
  • 10.1.5 Company Share Analysis 76
  • 10.1.6 Distribution Share Analysis 76
  • 10.1.7 Benchmarking 77
• 10.2 GlobalData Consulting 77
• 10.3 Contact Us 78